Cargando…
Pediatric cochlear implantation: an update
Deafness in pediatric age can adversely impact language acquisition as well as educational and social-emotional development. Once diagnosed, hearing loss should be rehabilitated early; the goal is to provide the child with maximum access to the acoustic features of speech within a listening range th...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282008/ https://www.ncbi.nlm.nih.gov/pubmed/25179127 http://dx.doi.org/10.1186/s13052-014-0072-8 |
_version_ | 1782351055252619264 |
---|---|
author | Vincenti, Vincenzo Bacciu, Andrea Guida, Maurizio Marra, Francesca Bertoldi, Barbara Bacciu, Salvatore Pasanisi, Enrico |
author_facet | Vincenti, Vincenzo Bacciu, Andrea Guida, Maurizio Marra, Francesca Bertoldi, Barbara Bacciu, Salvatore Pasanisi, Enrico |
author_sort | Vincenti, Vincenzo |
collection | PubMed |
description | Deafness in pediatric age can adversely impact language acquisition as well as educational and social-emotional development. Once diagnosed, hearing loss should be rehabilitated early; the goal is to provide the child with maximum access to the acoustic features of speech within a listening range that is safe and comfortable. In presence of severe to profound deafness, benefit from auditory amplification cannot be enough to allow a proper language development. Cochlear implants are partially implantable electronic devices designed to provide profoundly deafened patients with hearing sensitivity within the speech range. Since their introduction more than 30 years ago, cochlear implants have improved their performance to the extent that are now considered to be standard of care in the treatment of children with severe to profound deafness. Over the years patient candidacy has been expanded and the criteria for implantation continue to evolve within the paediatric population. The minimum age for implantation has progressively reduced; it has been recognized that implantation at a very early age (12–18 months) provides children with the best outcomes, taking advantage of sensitive periods of auditory development. Bilateral implantation offers a better sound localization, as well as a superior ability to understand speech in noisy environments than unilateral cochlear implant. Deafened children with special clinical situations, including inner ear malformation, cochlear nerve deficiency, cochlear ossification, and additional disabilities can be successfully treated, even thogh they require an individualized candidacy evaluation and a complex post-implantation rehabilitation. Benefits from cochlear implantation include not only better abilities to hear and to develop speech and language skills, but also improved academic attainment, improved quality of life, and better employment status. Cochlear implants permit deaf people to hear, but they have a long way to go before their performance being comparable to that of the intact human ear; researchers are looking for more sophisticated speech processing strategies as well as a more efficient coupling between the electrodes and the cochlear nerve with the goal of dramatically improving the quality of sound of the next generation of implants. |
format | Online Article Text |
id | pubmed-4282008 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-42820082015-01-03 Pediatric cochlear implantation: an update Vincenti, Vincenzo Bacciu, Andrea Guida, Maurizio Marra, Francesca Bertoldi, Barbara Bacciu, Salvatore Pasanisi, Enrico Ital J Pediatr Review Deafness in pediatric age can adversely impact language acquisition as well as educational and social-emotional development. Once diagnosed, hearing loss should be rehabilitated early; the goal is to provide the child with maximum access to the acoustic features of speech within a listening range that is safe and comfortable. In presence of severe to profound deafness, benefit from auditory amplification cannot be enough to allow a proper language development. Cochlear implants are partially implantable electronic devices designed to provide profoundly deafened patients with hearing sensitivity within the speech range. Since their introduction more than 30 years ago, cochlear implants have improved their performance to the extent that are now considered to be standard of care in the treatment of children with severe to profound deafness. Over the years patient candidacy has been expanded and the criteria for implantation continue to evolve within the paediatric population. The minimum age for implantation has progressively reduced; it has been recognized that implantation at a very early age (12–18 months) provides children with the best outcomes, taking advantage of sensitive periods of auditory development. Bilateral implantation offers a better sound localization, as well as a superior ability to understand speech in noisy environments than unilateral cochlear implant. Deafened children with special clinical situations, including inner ear malformation, cochlear nerve deficiency, cochlear ossification, and additional disabilities can be successfully treated, even thogh they require an individualized candidacy evaluation and a complex post-implantation rehabilitation. Benefits from cochlear implantation include not only better abilities to hear and to develop speech and language skills, but also improved academic attainment, improved quality of life, and better employment status. Cochlear implants permit deaf people to hear, but they have a long way to go before their performance being comparable to that of the intact human ear; researchers are looking for more sophisticated speech processing strategies as well as a more efficient coupling between the electrodes and the cochlear nerve with the goal of dramatically improving the quality of sound of the next generation of implants. BioMed Central 2014-09-02 /pmc/articles/PMC4282008/ /pubmed/25179127 http://dx.doi.org/10.1186/s13052-014-0072-8 Text en © Vincenti et al.; licensee BioMed Central Ltd. 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Review Vincenti, Vincenzo Bacciu, Andrea Guida, Maurizio Marra, Francesca Bertoldi, Barbara Bacciu, Salvatore Pasanisi, Enrico Pediatric cochlear implantation: an update |
title | Pediatric cochlear implantation: an update |
title_full | Pediatric cochlear implantation: an update |
title_fullStr | Pediatric cochlear implantation: an update |
title_full_unstemmed | Pediatric cochlear implantation: an update |
title_short | Pediatric cochlear implantation: an update |
title_sort | pediatric cochlear implantation: an update |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282008/ https://www.ncbi.nlm.nih.gov/pubmed/25179127 http://dx.doi.org/10.1186/s13052-014-0072-8 |
work_keys_str_mv | AT vincentivincenzo pediatriccochlearimplantationanupdate AT bacciuandrea pediatriccochlearimplantationanupdate AT guidamaurizio pediatriccochlearimplantationanupdate AT marrafrancesca pediatriccochlearimplantationanupdate AT bertoldibarbara pediatriccochlearimplantationanupdate AT bacciusalvatore pediatriccochlearimplantationanupdate AT pasanisienrico pediatriccochlearimplantationanupdate |